Demonstrating ROI to LPs and the Convergence Medtech, Biotech, and Digital, with Asabys Partners

In this episode, Henry Peck speaks with Clara Campàs and Josep Sanfeliu, the founders and managing partners of Asabys Partners, a venture capital firm active in the health tech and biopharma industries with an aim to invest in highly innovative and transformative technologies.Clara and Josep share their insights into building a thriving ecosystem that combines health tech, biotech, and medtech startups. From discussing their unique hybrid approach to investment to the strength of the Barcelona ecosystem, Clara and Josep explore how Asabys is contributing to the growth and global impact of healthcare innovation.Topics include:Clara and Josep’s journey founding Asabys Partners in 2018, with a vision of combining health tech and biotech to revolutionize healthcare investmentTheir recent success raising a $100 million fund Building a portfolio across a diverse range of technologies, clinical indications, and company stagesThe importance of demonstrating ROI beyond the traditional metricsInsights on the evolving IPO landscape, and how it has been affected by market trends and the pandemicClara and Josep’s actionable advice for entrepreneurs and investors navigating these dynamic industriesHow Barcelona's unique healthcare innovation ecosystem is rapidly evolvingClara and Josep’s upcoming participation at the LSI Europe ‘23 conference in September, where they will discuss these topics in greater detail<br/>And more!Transcript of episodeGuest links and resources:Connect with Clara Campàs: LinkedIn | TwitterConnect with Josep Sanfeliu: LinkedIn | TwitterAsabys Partners<br/>Connect with Henry: Twitter | LinkedInLearn more about LSISign up for LSI Europe '23<br/>Connect with LSI:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramConnect with Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook |